Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksINDOCO
resources
INDOCO

Indoco Remedies Ltd.

NSE: INDOCO
BSE: 532612
Sector: Healthcare
Industry: Pharmaceuticals
247.45-4.5 (-1.77%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Indoco Remedies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Indoco Remedies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Analyst / Investor Meet17 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter ended 30th June, 2026
  • Board Meeting15 Jul 2026
    Board Meeting Intimation for Unaudited Results For The Quarter Ended 30-06-2026
    Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve The Unaudited Standalone and ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Attached the certificate issued by MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, confirming compliance under Reg 74(5) of SEBI (D&P) Regulations,2018 for ....
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation regarding Closure of Trading Window
  • Press Release / Media Release26 Jun 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release : Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
  • Newspaper Publication11 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Notice for transfer of equity shares of the Company to the Investor Education and Protection Fund ("IEPF")
  • Press Release / Media Release28 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Indoco''s formulation plant at Baddi (Plant III) receives EU GMP Certification
  • Reg.24(A)-Annual Secretarial Compliance22 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Enclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe, Proprietor of M/s. A.Y.Sathe & Co, Company ....
  • Memorandum of Understanding /Agreements18 May 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Intimation regarding completion of transfer of Ophthalmic Division of the Company to Sunways (India) Private Limited
  • Demise15 May 2026
    Announcement under Regulation 30 (LODR)-Demise
    The Company hereby regrets to inform about the sad demise of Dr. Anand Nadkarni (DIN : 06881461) Non Executive Director of the Company today i.e. Friday, 15th May, 2026.
  • Press Release / Media Release14 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release:- Indoco Remedies successfully clears Malta Medicines Authority Audit
  • Newspaper Publication8 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Publication of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended 31-03-2026
  • Analyst / Investor Meet7 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026
  • Outcome of Board Meeting7 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th May, 2026
    Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors ....
  • Memorandum of Understanding /Agreements30 Apr 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Intimation regarding execution of Agreement to Transfer Business with Sunways (India) Private Limited
  • Press Release / Media Release30 Apr 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Indoco Remedies announces strategic transfer of its opthalmic division to Sunways India
  • Memorandum of Understanding /Agreements30 Apr 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Approval of Agreement to Transfer Business by Indoco Remedies Limited
  • Analyst / Investor Meet27 Apr 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of ECC on Audited Financial Results for Quarter and year ended 31-03-2026
  • Board Meeting27 Apr 2026
    Board Meeting Intimation for Board Meeting Intimation For Audited Results & Dividend
    Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....
  • General13 Apr 2026
    Update On The Company''s Testing Facility At Chhatrapati Sambaji Nagar - Aurangabad
    Pursuant to Regulation 30 of the SEBI (LODR)Regulations,2015, this is to inform you that the U.S. Food & Drug Administration completed Pre-approval inspection at the Company''s testing ....

Frequently Asked Questions

Where can I download the annual report of Indoco Remedies Ltd.?
Annual reports of Indoco Remedies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Indoco Remedies Ltd.?
Quarterly earnings results and presentations of Indoco Remedies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Indoco Remedies Ltd. publish earnings call transcripts?
Earnings call transcripts of Indoco Remedies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Indoco Remedies Ltd.?
Investor presentations and annual day presentations of Indoco Remedies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Indoco Remedies Ltd.?
Corporate announcements and regulatory filings of Indoco Remedies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Indoco Remedies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Indoco Remedies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Indoco Remedies Ltd.?
The ISIN (International Securities Identification Number) of Indoco Remedies Ltd. is INE873D01024. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Indoco Remedies Ltd. listed?
Indoco Remedies Ltd. is listed on NSE and BSE. The NSE symbol is INDOCO and the BSE code is -.
Where can I find the shareholding pattern of Indoco Remedies Ltd.?
The quarterly shareholding pattern of Indoco Remedies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Indoco Remedies Ltd. on Sharpely?
Share price data for Indoco Remedies Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.